We are excited to invite submissions to Drug Repurposing, the official journal of the REPO4EU (European Platform for Evidence-Based Repurposing of Medicines) project. As a diamond open access journal hosted on ScienceOpen, Drug Repurposing provides an innovative new option for publishing your cutting-edge research in drug repurposing. 

REPO4EU is a large-scale European initiative aimed at establishing a global open-access platform for evidence-based drug repurposing. This cross-disciplinary project brings together top experts, tools, and resources to accelerate the discovery and validation of new uses for existing drugs, ultimately making therapies more accessible and affordable worldwide. The journal Drug Repurposing plays a central role in this vision by offering researchers a space to share knowledge, collaborate, and drive the future of personalized medicine. 

The journal is led by an esteemed editorial team:

• Harald H.H.W. Schmidt, MD, PhD, PharmD – Professor of Pharmacology and Chair of the Department of Pharmacology and Personalized Medicine at Maastricht University, Netherlands
• Hermann Mucke, PhD – Biochemist and Molecular Biologist, CEO of H.M. Pharma Consultancy, Austria

Together, they bring decades of expertise in pharmacology, systems medicine, and translational science, ensuring the highest standards of academic rigor and innovation.

Why Publish in Drug Repurposing?

Interdisciplinary Focus
We welcome original research, reviews, brief communications, and perspective articles across diverse domains, including bioinformatics, high-throughput screening, clinical trial design, molecular pharmacology, health technology assessment, regulatory science, and ethical considerations.

Open Access and Global Visibility
All articles are published under the Creative Commons Attribution 4.0 (CC BY) license, ensuring that your research is freely available and globally accessible. There is no article processing charge (APC). 

Scientific Excellence and Rapid Publication
With a robust two-step peer review process, we offer high-quality editorial feedback and swift publication. Each manuscript submission undergoes an automated scientific rigor check powered by SciScore. Researchers receive feedback on how to improve the transparency and reproducibility of their work. Then it is reviewed by experts from the drug repurposing field. Manuscripts can be simultaneously posted on the preprint server DrugRxiv for rapid dissemination and open discussion during the peer review process. 

A Collaborative Ecosystem

As part of the REPO4EU project, Drug Repurposing is more than just a journal — it’s part of communication hub, DrugRepoCentral, with conference abstracts, the preprint server DrugRxiv, the Network and Systems Medicine over 10k research articles in the field. with a vibrant, interdisciplinary community working to transform the way we discover, evaluate, and deliver therapies. 

Join the Movement

By publishing in Drug Repurposing, you’re contributing to a growing movement that prioritizes open science, cross-sector collaboration, and patient-centered innovation.

Submit your manuscript today and be part of the next wave of breakthroughs in medicine.
🔗 Submit a manuscript

Join Our Network

At ScienceOpen, we are committed to fostering collaboration and innovation in scholarly publishing. We invite researchers, practitioners, and readers to join us in our mission to promote open access to knowledge and to facilitate the dissemination of groundbreaking research. Are you interested in exploring our publishing solutions or partnering with us? Contact us to learn more about how ScienceOpen can support your publishing needs. 

Stay Connected

Follow us on Bluesky and X at @Science_Open to keep up to date on news, announcements, and new content on ScienceOpen.